News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
703,551 Results
Type
Article (41888)
Company Profile (486)
Press Release (661177)
Section
Business (209312)
Career Advice (2014)
Deals (36043)
Drug Delivery (92)
Drug Development (83459)
Employer Resources (169)
FDA (16360)
Job Trends (15103)
News (353380)
Policy (33103)
Tag
Academia (2636)
Alliances (50861)
Alzheimer's disease (1274)
Approvals (16277)
Artificial intelligence (134)
Bankruptcy (364)
Best Places to Work (11756)
Biotechnology (364)
Breast cancer (120)
Cancer (1064)
Cardiovascular disease (90)
Career advice (1682)
Cell therapy (237)
Clinical research (66003)
Collaboration (385)
Compensation (190)
COVID-19 (2597)
C-suite (92)
Data (1061)
Diabetes (154)
Diagnostics (6213)
Earnings (86184)
Employer resources (147)
Events (113339)
Executive appointments (285)
FDA (16875)
Funding (345)
Gene therapy (185)
GLP-1 (610)
Government (4423)
Healthcare (19026)
Infectious disease (2679)
Inflammatory bowel disease (113)
Interviews (309)
IPO (16583)
Job creations (3731)
Job search strategy (1439)
Layoffs (443)
Legal (7973)
Lung cancer (169)
Manufacturing (177)
Medical device (13337)
Medtech (13342)
Mergers & acquisitions (19505)
Metabolic disorders (416)
Neuroscience (1546)
NextGen Class of 2024 (6767)
Non-profit (4547)
Northern California (1434)
Obesity (240)
Opinion (198)
Patents (99)
People (57923)
Phase I (20687)
Phase II (29136)
Phase III (21544)
Pipeline (445)
Postmarket research (2593)
Preclinical (8885)
Radiopharmaceuticals (250)
Rare diseases (221)
Real estate (6056)
Regulatory (22002)
Research institute (2412)
Resumes & cover letters (352)
Southern California (1290)
Startups (3785)
United States (13478)
Vaccines (566)
Weight loss (182)
Date
Today (59)
Last 7 days (937)
Last 30 days (3610)
Last 365 days (36629)
2024 (33181)
2023 (41084)
2022 (52343)
2021 (56855)
2020 (55004)
2019 (47533)
2018 (35811)
2017 (33143)
2016 (32491)
2015 (38552)
2014 (32359)
2013 (27313)
2012 (29446)
2011 (30047)
2010 (28221)
Location
Africa (733)
Arizona (198)
Asia (38682)
Australia (6446)
California (3295)
Canada (1261)
China (243)
Colorado (146)
Connecticut (153)
Europe (84499)
Florida (441)
Georgia (112)
Illinois (353)
Indiana (194)
Kansas (100)
Maryland (581)
Massachusetts (2654)
Michigan (155)
Minnesota (274)
New Jersey (940)
New York (943)
North Carolina (749)
Northern California (1434)
Ohio (136)
Pennsylvania (825)
South America (1108)
Southern California (1290)
Texas (451)
Utah (90)
Washington State (369)
703,551 Results for "argos therapeutics inc formerly merix bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Spur Therapeutics (Formerly Freeline) Announces New Name and Brand
Spur Therapeutics, formerly Freeline Therapeutics, today announced a new name and brand to reflect its focus on developing a new generation of gene therapies and advancing the practice of genetic medicine.
June 17, 2024
·
5 min read
Press Releases
StimCell Energetics Inc. (Formerly “Cell MedX Corp.”) Announces Major Corporate Updates and Rebranding
November 4, 2024
·
3 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Biotech Bay
Alamar Biosciences Announces Commercial Launch of the ARGO™ HT System and the NULISAseq™ Inflammation Panel 250 for Ultra-high Sensitivity Protein Analysis in Biofluids
Alamar Biosciences announced the commercial launch of the ARGO HT System for push-button, high sensitivity analysis of proteins in biofluids and the NULISAseq Inflammation Panel 250 for deep profiling of immune response.
January 4, 2024
·
3 min read
Business
Ankyra Therapeutics and Jenga Biosciences Announce Exclusive License Agreement for JEN-101
Ankyra Therapeutics and Jenga Biosciences are pleased to announce today an exclusive license agreement to develop and commercialize JEN-101 (formerly known as cANK-101).
March 26, 2024
·
4 min read
Deals
Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets
Harmony Biosciences, announced the acquisition of Epygenix Therapeutics, Inc., accelerating its growth strategy by adding a rare epilepsy franchise to its expanding late-stage pipeline of innovative CNS assets.
April 30, 2024
·
9 min read
Press Releases
Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply
November 12, 2024
·
4 min read
Press Releases
Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update
November 14, 2024
·
8 min read
Press Releases
Xenetic Biosciences, Inc. Reports Third Quarter 2024 Financial Results
November 13, 2024
·
6 min read
Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis
Shanghai Argo Biopharmaceutical Co., Ltd. announced that it has entered into two exclusive license and collaboration agreements with Novartis PHARMA AG.
January 7, 2024
·
3 min read
1 of 70,356
Next
